IP Library Granted Patent US 9,095,555
Granted Patent B2
US 9,095,555 · App. 14/312,570 · Granted Aug 4, 2015

Cannabinoid formulations

Inventor: Robert Winnicki (Denver, CO)
Assignee: FULL SPECTRUM LABORATORIES, LIMITED
A61K36/185A23L1/3002A61K9/107A61K9/1075A61K9/127A61K31/05A61K31/352A61K45/06A61K47/10A61K47/24A61K47/36
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,095,555
App. No.
14/312,570
Granted
Aug 4, 2015
Kind
B2
Abstract

The present invention provides stable, fast-acting liposomal and micelle formulations of cannabinoids that are suitable for pharmaceutical and nutraceutical applications.

Claims (20)

1. A method of producing a suspension of particles of one or more cannabinoids in aqueous media consisting of the steps of:

(a) dissolving one or more cannabinoids in ethanol to obtain an ethanol cannabinoid solution;

(b) injecting the ethanol cannabinoid solution into distilled water; and

(c) removing the ethanol from the composition from step (b), thereby producing a suspension of particles of one or more cannabinoids in aqueous media;

(d) optionally adding stabilizer after the ethanol has been removed;

wherein the particles of one or more cannabinoids show no aqueous core under oil immersion microscopy.

2. The method of claim 1 , wherein the average particle diameter in the aqueous cannabinoid suspension is in a range between 50 and 1000 nm, and wherein the concentration of cannabinoids in the aqueous cannabinoid suspension is from about 1.0 g/liter to about 2 g/liter.

3. The method of claim 1 , wherein the one or more cannabinoids are selected from the group consisting of natural compounds, synthetic compounds, semi-synthetic compounds, and mixtures thereof.

4. The method of claim 3 , wherein the one or more cannabinoids are selected from the group consisting of cannabinol, cannabidiol, Δ9-tetrahydrocannabinol, Δ8-tetrahydrocannabinol, 11-hydroxy-tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol, levonatradol, Δ11-tetrahydrocannabinol, tetrahydrocannabivarin, dronabinol, amandamide, nabilone, and combinations thereof.

5. The method of claim 1 wherein the stabilizer is present and is guar gum.

6. A method of producing a suspension of particles of one or more cannabinoids in aqueous media consisting of the steps of:

(a) providing plant material from a cannabis plant;

(b) subjecting the plant material from step (a) to supercritical fluid extraction to obtain an extract of cannabinoids;

(c) dissolving the extract of step (b) in ethanol to obtain an ethanol cannabinoid solution;

(d) injecting the ethanol cannabinoid solution into distilled water; and

(e) removing the ethanol from the composition from step (d), thereby producing a suspension of particles of one or more cannabinoids in aqueous media;

(f) optionally adding stabilizer after the ethanol has been removed;

wherein the particles of one or more cannabinoids show no aqueous core under oil immersion microscopy.

7. The method of claim 6 , wherein the average particle diameter in the aqueous cannabinoid suspension is in a range between 50 and 1000 nm, and wherein the concentration of cannabinoids in the aqueous cannabinoid suspension is from about 1.0 g/liter to about 2 g/liter.

8. The method of claim 6 wherein the stabilizer is present and is guar gum.

Assignments (7)
SECURITY INTEREST Recorded Nov 23, 2021
From: TEEWINOT TECHNOLOGIES LIMITED
To: TUATARA CAPITAL FUND I, L.P.; TUATARA CAPITAL PARALLEL FUND I, L.P.
Reel/Frame 058194/0448 →
SECURITY INTEREST Recorded Nov 23, 2021
From: TEEWINOT LIFE SCIENCES CORPORATION; TEEWINOT TECHNOLOGIES LIMITED
To: TUATARA CAPITAL FUND I, L.P.; TUATARA CAPITAL PARALLEL FUND I, L.P.
Reel/Frame 058194/0474 →
SECURITY INTEREST Recorded Nov 22, 2021
From: TEEWINOT TECHNOLOGIES LIMITED
To: TUATARA CAPITAL FUND I, L.P.; TUATARA CAPITAL PARALLEL FUND I, L.P.
Reel/Frame 058180/0377 →
SECURITY INTEREST Recorded Nov 22, 2021
From: TEEWINOT LIFE SCIENCES CORPORATION; TEEWINOT TECHNOLOGIES LIMITED
To: TUATARA CAPITAL FUND I, L.P.; TUATARA CAPITAL PARALLEL FUND I, L.P.
Reel/Frame 058182/0033 →
SECURITY INTEREST Recorded Aug 24, 2020
From: TEEWINOT TECHNOLOGIES, LTD.
To: TUATARA CAPITAL FUND I, L.P.
Reel/Frame 053582/0897 →
CHANGE OF NAME Recorded Dec 8, 2017
From: FULL SPECTRUM LABORATORIES LIMITED
To: TEEWINOT TECHNOLOGIES LIMITED
Reel/Frame 044804/0125 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2016
From: WINNICKI, ROBERT
To: FULL SPECTRUM LABORATORIES LIMITED
Reel/Frame 040184/0341 →
Continuity (3)
Division 13547039 · Jul 11, 2012
Provisional Application 61506331 · Jul 11, 2011
Related Publication 20140302148A1 · Oct 9, 2014